Trial
NCT05405257
Oxytocin for Hypermobile Ehlers-Danlos Syndrome
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Baylor College of Medicine
Collaborators
—
Condition
Hypermobile Ehlers-Danlos Syndrome
Intervention
Oxytocin
Why stopped
Study team has decided to close the trial (NCT05405257) due problems with patient recruitment and enrollment efforts. To date, only one patient completed both arms.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-28